Advanced Biomed Inc Cash
Advanced Biomed Inc (ADVB) had Cash of $2.60 million as of 2025-12-31, per its 10-Q filed 2026-02-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:Cash · last filed 2026-02-13
- 2025-12-31: Cash $2.60M.
- 2025-09-30: Cash $2.66M.
- 2025-06-30: Cash $2.87M; Cash as first filed $2.90M.
- 2025-03-31: Cash $5.18M.
| Period end | Cash | Cash as first filed |
|---|---|---|
| 2025-12-31 | $2.60M 10-Q · filed 2026-02-13 | |
| 2025-09-30 | $2.66M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $2.87M 10-Q · filed 2026-02-13 | $2.90M 10-K · filed 2025-10-08 |
| 2025-03-31 | $5.18M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $2.66M 10-Q · filed 2025-04-15 | |
| 2024-06-30 | $2.61M 10-K · filed 2025-10-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |